Shingles Vaccine Lowers Dementia Risk by 20%

Tejal Somvanshi

Getting vaccinated against shingles does more than just prevent a rash; recent research reveals it might also protect your brain health as you age.

Photo Credits: Nataliya Vaitkevich (Pexels)

In 2013, Welsh health officials made the Zostavax shingles vaccine available only to people born on or after September 2, 1933. This helped in studying the difference in the two groups of people over time.

Photo Source: Harabe 1001 (Pexels)

The results from the research reveal that those who received the vaccine showed a 20% lower risk of dementia, with women having a greater benefit than men.

Photo Credits: Kindel Media (Pexels)

The virus that causes shingles (varicella-zoster virus) can trigger inflammation throughout the nervous system, infect the blood vessels and increase the risk of stroke and dementia.

Photo Credits: B.G. Partin (CC BY-SA 4.0)

The older Zostavax vaccine, whose use has been steadily decreasing, has been replaced with a newer, much more effective vaccine called Shingrix.

Photo Source: Whispy History (CC BY-SA 4.0)

Shingrix requires two doses given a few months apart, and the healthcare providers advise not to take the vaccine immediately after being affected by other illnesses like the flu or COVID-19.

Photo Source: Maksim Goncharenok (Pexels)

Apart from this vaccine, staying socially and mentally active promises brain protection. Controlling blood pressure and managing blood sugar are other key steps in lowering dementia.

Photo Credits: Ivan Samkov (Pexels)

Around 55 million people are affected by dementia. While there is no proper cure yet, these new findings offer a newfound hope in the battle against cognitive decline.

Photo Source: Hasan Albari (Pexels)